Parallel Advisors, LLC Bausch Health Companies Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,221 shares of BHC stock, worth $10,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,221

Previous 1,431 14.68%

Holding current value

$10,354

Previous $9,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $1,096 - $1,734	-210 Reduced 14.68%	1,221 $9,000
Q2 2024 Aug 08, 2024	SELL	$6.1 - $10.41 $6,069 - $10,357	-995 Reduced 41.01%	1,431 $9,000
Q1 2024 May 06, 2024	BUY	$7.77 - $10.61 $8,741 - $11,936	1,125 Added 86.47%	2,426 $25,000
Q4 2023 Feb 09, 2024	SELL	$6.53 - $8.23 $8,018 - $10,106	-1,228 Reduced 48.56%	1,301 $10,000
Q3 2023 May 20, 2024	SELL	$7.69 - $9.71 $5,636 - $7,117	-733 Reduced 22.47%	2,529 $20,000
Q3 2023 Nov 13, 2023	SELL	$7.69 - $9.71 $5,636 - $7,117	-733 Reduced 22.47%	2,529 $20,000
Q2 2023 May 20, 2024	BUY	$5.72 - $8.8 $6,801 - $10,463	1,189 Added 57.36%	3,262 $26,000
Q2 2023 Aug 04, 2023	BUY	$5.72 - $8.8 $6,801 - $10,463	1,189 Added 57.36%	3,262 $26,000
Q1 2023 May 20, 2024	SELL	$6.28 - $9.85 $2,216 - $3,477	-353 Reduced 14.55%	2,073 $16,000
Q1 2023 Apr 25, 2023	SELL	$6.28 - $9.85 $62,511 - $98,046	-9,954 Reduced 82.76%	2,073 $16,000
Q4 2022 Feb 03, 2023	SELL	$6.09 - $7.93 $24,895 - $32,417	-4,088 Reduced 25.37%	12,027 $75,000
Q3 2022 Nov 10, 2022	SELL	$4.58 - $9.21 $8,642 - $17,379	-1,887 Reduced 10.48%	16,115 $111,000
Q2 2022 Aug 01, 2022	BUY	$7.06 - $23.63 $99,637 - $333,490	14,113 Added 362.9%	18,002 $150,000
Q1 2022 Apr 28, 2022	SELL	$21.6 - $27.79 $2,764 - $3,557	-128 Reduced 3.19%	3,889 $90,000
Q4 2021 Jan 20, 2022	BUY	$23.0 - $29.01 $48,783 - $61,530	2,121 Added 111.87%	4,017 $111,000
Q3 2021 Nov 02, 2021	BUY	$25.04 - $30.06 $2,253 - $2,705	90 Added 4.98%	1,896 $53,000
Q2 2021 Aug 06, 2021	BUY	$27.43 - $32.7 $493 - $588	18 Added 1.01%	1,806 $53,000
Q1 2021 Apr 23, 2021	SELL	$21.37 - $34.38 $3,483 - $5,603	-163 Reduced 8.35%	1,788 $57,000
Q4 2020 Feb 02, 2021	BUY	$15.31 - $21.12 $8,343 - $11,510	545 Added 38.76%	1,951 $41,000
Q3 2020 Oct 27, 2020	SELL	$14.88 - $20.13 $15,683 - $21,217	-1,054 Reduced 42.85%	1,406 $22,000
Q2 2020 Jul 16, 2020	BUY	$13.31 - $20.51 $31,717 - $48,875	2,383 Added 3094.81%	2,460 $44,000
Q1 2020 Apr 27, 2020	SELL	$12.98 - $30.25 $623 - $1,452	-48 Reduced 38.4%	77 $1,000
Q4 2019 Jan 30, 2020	SELL	$18.89 - $31.89 $170,010 - $287,010	-9,000 Reduced 98.63%	125 $4,000
Q3 2018 Nov 01, 2018	BUY	$20.64 - $25.67 $188,340 - $234,238	9,125 New	9,125 $234,000

Others Institutions Holding BHC

# of Institutions

255

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Bausch Health Companies Inc. Transaction History